Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 4/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | TET3 | O43151 | 1/20 | 0.30 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.30 |
| ▸ | MGAM | O43451 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 2/20 | 0.30 |
| ▸ | SI | P14410 | 2/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL6333244 | 0.98 | ALDH1A1 (0.60) | ALDH1A1TSHRTHRBHSD17B10EGLN1 | |
| Methacrylic Acid SCHEMBL10809031 | 0.96 | ALDH1A1 (0.58) | ALDH1A1TSHRTHRBHSD17B10EGLN1 | |
| Dimethylamine SCHEMBL28516615 | 0.96 | ALDH1A1 (0.58) | ALDH1A1TSHRTHRBHSD17B10EGLN1 | |
| Trimethylammonium SCHEMBL7158254 | 0.93 | ALDH1A1 (0.54) | ALDH1A1TSHRTHRB | |
| Trimethylammonium SCHEMBL9567820 | 0.93 | ALDH1A1 (0.54) | ALDH1A1TSHRTHRB | |
| Butadiene SCHEMBL16428537 | 0.93 | ALDH1A1 (0.54) | ALDH1A1TSHRTHRBHSD17B10ALOX15 | |
| SCHEMBL10958139 | 0.87 | ALDH1A1 (0.42) | ALDH1A1TSHRTHRBHSD17B10ALOX15 | |
| SCHEMBL10425309 | 0.87 | ALDH1A1 (0.68) | ALDH1A1TSHRTHRBHSD17B10EGLN1 | |
| SCHEMBL14353766 | 0.87 | ALDH1A1 (0.47) | ALDH1A1TSHRTHRBTDP1 | |
| Methacrylic Acid SCHEMBL27490392 | 0.85 | ALDH1A1 (0.52) | ALDH1A1TSHRTHRBHSD17B10EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384145-A1 | PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF KETAMINE DERIVATIVES | XWPharma Ltd. (KY) | 2024-06-19 | — | — | EP | claimed |
| WO-2023174433-A1 | SOLID, SEMISOLID, OR LIQUID COMPOSITIONS FOR AUGMENTING THE STABILITY, PERMEABILITY AND BIOAVAILABILITY OF ACTIVE PHARMACEUTICAL SUBSTANCES | Smart Pharmaceutical (Suzhou) Co., Ltd. (CN) | 2023-09-21 | — | — | WO | claimed |
| WO-2023018966-A1 | PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF KETAMINE DERIVATIVES | XWPharma Ltd. (KY) | 2023-02-16 | — | — | WO | claimed |
| CN-106784533-B | A kind of production technology of the copolymer coated diaphragm containing PMMA | 东莞市卓高电子科技有限公司 | 2019-09-13 | — | — | CN | claimed |
| US-20180153812-A1 | ALCOHOL RESISTANT DOSAGE FORMS | EURO-CELTIQUE S.A. (LU) | 2018-06-07 | — | — | US | claimed |
| CN-106784533-A | A kind of production technology containing PMMA and its copolymer coated barrier film | 东莞市卓高电子科技有限公司 | 2017-05-31 | — | — | CN | claimed |
| US-20170079923-A1 | ALCOHOL RESISTANT DOSAGE FORMS | EURO-CELTIQUE S.A. (LU) | 2017-03-23 | — | — | US | claimed |
| EP-1937222-B1 | NEW SUSTAINED-RELEASE MULTIPLE UNIT DOSAGE FORM | GL PHARMTECH CORP (KR) | 2014-02-26 | — | — | EP | claimed |
| US-20140021400-A1 | PRINTABLE ETCHANT COMPOSITIONS FOR ETCHING SILVER NANOWARE-BASED TRANSPARENT, CONDUCTIVE FILM | SUN CHEMICAL CORPORATION (US) | 2014-01-23 | — | — | US | claimed |
| EP-2651841-A1 | PRINTABLE ETCHANT COMPOSITIONS FOR ETCHING SILVER NANOWIRE-BASED TRANSPARENT, CONDUCTIVE FILMS | Sun Chemical Corporation (US) | 2013-10-23 | — | — | EP | claimed |
| EP-1937222-A1 | NEW SUSTAINED-RELEASE MULTIPLE UNIT DOSAGE FORM | GL PharmTech Corp. (KR) | 2008-07-02 | — | — | EP | claimed |
| WO-2007046590-A1 | NEW SUSTAINED-RELEASE MULTIPLE UNIT DOSAGE FORM | GL PHARMTECH CORP. (KR) | 2007-04-26 | — | — | WO | claimed |
| EP-1771160-A2 | ALCOHOL RESISTANT DOSAGE FORMS | Euroceltique S.A. (LU) | 2007-04-11 | — | — | EP | claimed |
| WO-2006079550-A2 | ALCOHOL RESISTANT DOSAGE FORMS | EURO-CELTIQUE S.A. (LU) | 2006-08-03 | — | — | WO | claimed |
| US-5817340-A | Pharmaceutical compositions containing famotidine and aluminum hydroxide or magnesium hydroxide | MCNEIL-PPC, INC. (US) | 1998-10-06 | — | — | US | claimed |
| EP-0600725-B1 | Pharmaceutical compositions containing a guanidinothiazole and antacids | MCNEIL PPC INC (US) | 1997-09-17 | — | — | EP | claimed |
| US-5593696-A | ORAL DOSAGE FORM, THE FAMOTIDINE HAVING BARRIER LAYER PREVENTING ITS INTERACTION WITH SUCRALFATE IN DOSAGE FORM | MCNEIL-PPC, INC. (US) | 1997-01-14 | — | — | US | claimed |
| WO-1996015775-A1 | STABILIZED COMPOSITION OF FAMOTIDINE AND SUCRALFATE FOR TREATMENT OF GASTROINTESTINAL DISORDERS | MCNEIL-PPC, INC. (US) | 1996-05-30 | — | — | WO | claimed |
| EP-0600725-A1 | Pharmaceutical compositions containing a guanidinothiazole and antacids | McNEIL-PPC, INC. (US) | 1994-06-08 | — | — | EP | claimed |
| EP-0238974-B1 | HEAT RESISTANCE-IMPROVED METAL-POLYPROPYLENE LAMINATE COMPOSITE | Chisso Corporation (JP) | 1991-12-27 | — | — | EP | claimed |